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Introduction
The use of  herbal medicines in the prevention and 
treatment of  diseases has long been implemented by our 
ancestors since the dawn of  medicine. This empirical 
effort has contributed to the discovery of  synthetic drugs 
started in the nineteenth century. This advance has brought 
the medicine to an era of  synthetic drugs dominated by 
pharmaceutical companies, marked by a concept of  mono-
drug therapy and less interest to use natural products. 
However, the World Health Organization (WHO) has 
announced that at least 70% of  the world’s population 
count on traditional medicines for primary healthcare [1]. 
In addition, the interest in bringing traditional medicines 
into practices is growing rapidly across countries. These 
include the use of  plants extracts along with their chemical 
constituents. Therefore, herbal medicines remain to play a 
significant role in the era of  modern medicine [2,3].
One of  the natural products that have gained 
much interest is Eleutherine americana Merr. Having been 
used traditionally in the treatment of  many diseases, 
e.g. cancer and cardiovascular diseases, this medicinal 
plant is considered promising for future development 
of  drugs. Many researchers have investigated not only 
pharmacological activities of  the plant but also its 
chemical constituents that might be responsible for the 
therapeutic effect. Some major compounds that have been 
successfully isolated are classified to three big groups: 
naphthalene, anthraquinone and naphthoquinone [4–6]. 
The pharmacological activities of  extracts and chemical 
constituents derived from the bulb of  the plant include 
antimicrobial, anti-inflammatory, antidiabetic, and 
cytotoxic [7]. 
 In the cardiovascular system, E. americana has been 
reported to exhibit vasodepressant properties. In addition, 
the chemical compound in this plant is also capable of  
increasing the coronary flow in the heart of  guinea pig 
[8,9]. More recently, a report from Indonesia suggested 
that the extract of  the plant shows the blood pressure 
lowering effect in hypertensive rats induced by fructose 
with a marked increase in urine production [10]. However, 
there is no further report on whether the extract also 
exhibits antihypertensive activity in other models of  
hypertension. The objective of  the present study was to 
investigate the blood pressure 
lowering effect of  E. americana 
extract in the hypertensive rats 
induced by prednisone and salt. 
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ABSTRACT: The effect of ethanolic extract of Eleutherine americana Merr. on the blood pressure and heart rate has been 
investigated. A number of 25 Sprague-Dawley male rats were induced with prednisone 1.5 mg/kg in combination with saline 
solution 2.5% for 14 days to obtain hypertension model. The rats were anesthetized and prepared for the recording of blood 
pressure and heart rate. The rats were divided into five groups receiving 100, 200, and 400 mg/kg of the extract, vehicle control, 
and captopril 30 mg/kg as the reference. The treatment was administered three times with 30 minutes interval. The systolic (SBP), 
diastolic (DBP), mean arterial pressure (MAP), and heart rate (HR) were recorded. The data were analyzed with two-way analysis 
of variance (ANOVA) followed by Duncan’s MRT (95% confidence interval). The study revealed that the extract exhibited a blood 
pressure lowering effect. The best antihypertensive activity of the extract was shown by the dose of 100 mg/kg. Meanwhile, HR 
was also affected inversely by the treatment, in which the lowest dose caused the highest increase. The study suggests that the 
extract of Eleutherine americana exhibits antihypertensive activity that may be potential for future development of drugs.
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The finding of  the study was expected to provide more 
data on the possible pharmacological activities of  the plant 
for the future development of  the plant for pharmaceutical 
purposes. 
Methods
Drug and chemicals
Prednisone and captopril were obtained from a local 
pharmacy. Propofol (Fresofol®) was a product of  PT 
Fresenius Kabi (Jakarta, Indonesia). Heparin and NaCl 
0.9% intravenous infusion were products of  BBraun 
(Jakarta, Indonesia). Ethanol 70% and distilled water were 
purchased from Bratachem (Brataco PT, Indonesia). All 
materials were used as received. 
Extract preparation 
Eleutherine americana Merr plants were obtained from 
Padang City, West Sumatra, Indonesia and identified in 
Herbarium of  Andalas University (ANDA). About 500 
g of  the shade-dried bulb of  the sample was powdered 
and extracted with ethanol by maceration method. The 
extraction was conducted three times and considered 
complete when the macerate gradually turned colorless. The 
solvent extract was concentrated by a rotary evaporator. 
The extract underwent the preliminary phytochemical test.
Animal preparation
A number of  25 adult male Sprague-Dawley 
rats (weighed ±250 g and aged 3-4 months old) were 
acclimatized to normal laboratory condition. Standard 
chow and water ad libitum were provided. The animals were 
induced with prednisone 1.5 mg/kg in combination with 
2.5% salt solution for 14 days. Hypertension was indicated 
if  the mean arterial pressure was above 150 mmHg [11]. 
All protocols of  the experiment were approved by the 
ethics committee of  the Faculty of  Medicine, Andalas 
University (152/KEP/FK/2018).
Antihypertensive activity evaluation
The rats received propofol 150 mg/kg 
intraperitoneally to induce sedation for anesthetized 
blood pressure monitoring. The direct measurement of  
the blood pressure was conducted through the carotid 
artery by using arterial cannula connected to a pressure 
transducer and hemodynamic recorder (Biopac MP 150, 
USA). The left jugular vein was prepared for saline-heparin 
and supplementary infusion of  propofol 4% infusion by 
using PP 50 tubing. The rats were divided into five groups 
receiving vehicle control; extract 100, 200, and 400 mg/kg; 
and captopril 30 mg/kg as the reference. The treatment 
was administered three times with 30 minutes interval. 
The systolic blood pressure (SBP), diastolic blood pressure 
(DBP), mean arterial pressure (MAP) and heart rate (HR) 
were recorded for further analysis [12]. 
Data Analysis
Data were presented as the mean of  percent change 
± standard deviation (SD). The data were analyzed by 
using two-way analysis of  variance (ANOVA). Significant 
differences were followed by Duncan’s MRT (Multiple 
Range Test). The significance level was taken at 95% 
confidence interval for all analyses
Result dan Discussion
The phytochemical and pharmacological properties 
of  Eleutherine americana Merr. have gained more interest 
since the mid of  the 1990s. This medicinal plant 
originated in tropical America are currently cultivated 
across the globe. In Indonesia, it is well known as 
“bawang dayak”, representing the native tribe in Borneo 
island, the place where it has been widely cultivated. 
Along with the publication of  popular articles over the 
internet claiming the benefit of  consuming the herbs of  
this plant, extensive researches have reported its potential 
development for pharmaceutical purposes. These include 
its pharmacological activities against bacteria and virus, to 
reduce the inflammation, high blood sugar, and within the 
cardiovascular system [7]. 
Many reports on the pharmacological activities of  E. 
americana in the cardiovascular system has been published. 
Among these, some may be potential to lower the high 
blood pressure such as reducing the tone of  blood vessels 
and increasing the coronary flow [8,9]. The extract of  
this plant has also been reported to reduce the blood 
pressure of  rats induced with high fructose, causing an 
increase in urine volume and improved cardiogram profile 
Table 1. Preliminary test results of  chemical constituents 
of  E. americana extract
Compound groups Results of examination 
Flavonoids +
Alkaloids +
Triterpenoids +
Steroids +
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[10]. Although many reports have suggested the potential 
antihypertensive effect of  the plant, the investigation of  
the effect on endocrine-related hypertension has not been 
reported to our knowledge. The present study was aimed 
to explore the blood pressure lowering activity of  E. 
americana extract in prednisone-salt-induced hypertensive 
rats. 
The preliminary qualitative determination on the 
extract contents of  E. americana on the present study 
showed that the extract contained flavonoids, alkaloids, 
triterpenoids, and steroids (Table 1), confirming the 
finding of  a previous study [10]. The present study did 
not further determine the chemical contents into a specific 
classification. Nevertheless, some major compound groups 
with interesting biological activities have been reported: 
naphthalene, anthraquinone and naphthoquinone. 
Some other compounds have also been isolated such as 
stigmasterol and kadsuric acid [5,7].  
The main results of  the present study showed that 
the extract significantly influenced the systolic, diastolic, 
and mean arterial pressure. Figure 1 roughly demonstrates 
the extent of  blood pressure lowering effect of  the extract 
to the mean arterial pressure (MAP) after three repetitive 
administration. Among three different doses tested, the 
Figure 1. Comparative changes of  mean arterial pressure due to the treatment of  extract of  Eleutherine americana
Figure 2. Comparative changes of  heart rate due to the treatment of  extract of  Eleutherine americana
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lowest dose 100 mg/kg exhibited better blood pressure 
lowering activity for SBP, DBP and MAP than larger 
doses. Interestingly, higher doses (200 and 400 mg/kg) 
tent to possess contrary effect as compared with 100 mg/
kg dose and increased the blood pressure even higher than 
the control did. The study also showed that the effect of  
the extract to the blood pressure was not significantly 
different from that of  captopril (p>0.05).
The extract also influenced the heart rate (HR) 
significantly (p<0.05). However, the lowest dose 100 mg/
kg demonstrated a higher increase of  HR as compared 
with other extract doses (Figure 2). In contrast, the 
most elevated heart rate was shown by captopril. This 
phenomenon may be closely related to the theory of  blood 
pressure calculation, in which the heart rate is affecting the 
blood pressure inversely [13]. A similar circumstance was 
also seen in most of  our previous antihypertensive studies 
[11,14,15].
Further examination on the effect of  the extract to 
the systolic, diastolic, and mean arterial pressure and heart 
rate showed are demonstrated by Figure 3-5, showing that 
the extract at the dose of  100 mg/kg exhibits better blood 
pressure lowering effect as compared with other doses. 
Meanwhile, Figure 6 illustrates different trend which is 
previously mentioned. 
The measurement of  the blood pressure was 
undertaken through the cannulation of  the carotid artery–
known as the direct method. Some of  our previous 
Figure 3. Comparative effect of  intraperitoneal administration of  extract of  Eleutherine 
americana to the SBP (systolic blood pressure)
Figure 4. Comparative effect of  intraperitoneal administration of  extract of  Eleutherine 
americana to the DBP (diastolic blood pressure)
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studies have suggested that this method were capable of  
coping the whole techniques used in the study, including 
the use of  prednisone and salt as inducers to obtain 
experimental animals with elevated blood pressure [11,15]. 
In addition, despite invasive and requires some minor 
surgical procedures, the direct method in measuring blood 
pressure is considered as a gold standard for this purpose 
[16]. This includes the preliminary study of  plants extract 
to investigate their potential blood pressure lowering 
activity [17].
Although a previous study has suggested that the 
ethanol extract of  E. americana exhibited antihypertensive 
activity [10], the present study provides its own significance 
to support the blood pressure lowering effect of  the extract 
due to the use of  different inducer of  hypertension, thus 
different type of  hypertension. It has been suggested 
that using some different animal models is necessary for 
the evaluation of  a potential agent or plant extract. This 
Figure 5. Comparative effect of  intraperitoneal administration of  extract of  Eleutherine 
americana to the MAP (mean arterial pressure)
Figure 6. Comparative effect of  intraperitoneal administration of  extract of  Eleutherine 
americana to the HR (heart rate)
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is due to the complexity of  human hypertension which 
is sometimes considered multifactorial [18]. In addition, 
the disease of  elevated blood pressure itself  is divided 
into essential and secondary hypertension where each 
of  them is likely to exhibit different pathogenesis and 
characteristics [19]. 
The use of  intraperitoneal injection in administering 
the extract in the present study was somewhat different from 
most of  the similar studies. This route of  administration 
is commonly used in small animals like mice and rats 
but rarely used in larger ones. Herein, this technique was 
used since the intravenous administration might not be 
feasible due to the high volume of  administration and 
the characteristics of  the extract. In addition, despite this 
method is parenteral access, the pharmacokinetics of  the 
injected substance is considered comparable with the oral 
route of  administration [20].  Yet, the use of  this route 
might have influenced the degree of  the blood pressure 
lowering effect of  the extract and the doses as well. When 
compared with a previous study by Hasimun et al. [10] 
who administered the extract orally, the present study 
used larger doses with a comparable extent of  the effect. 
Interestingly, one clear similarity between these two studies 
is that the best effect was shown by the smallest dose. 
The antioxidant properties of  E. americana have 
also gained interest alongside with its mostly reported 
antimicrobial activity. The antioxidant capacity of  
the plant is likely associated with the high content of  
naphthoquinones, one of  the major compounds reported 
from the plant [21]. Although the present study did not 
evaluate the antioxidant capacity of  the plant nor its 
correlation to the blood pressure lowering effect, it has 
been well recognized that antioxidants may be beneficial 
in reducing the high blood pressure. Some popular studies 
have proposed the antihypertensive effect of  well-known 
antioxidants. These include those from vitamin C and E 
[22,23] and tempol [24,25]. This perspective indicates that 
the future development of  blood pressure lowering agent 
from E. americana is somewhat promising.
Conclusion
The study concludes that the extract of  Eleutherine 
americana Merr. exhibits an antihypertensive activity which 
lowers the systolic, diastolic, and mean arterial pressure 
of  hypertensive rats induced by prednisone and salt. The 
best effect of  the extract is demonstrated by the dose 
of  100 mg/kg, which is not significantly different to 
captopril. Meanwhile, this dose increases the heart rate 
higher than other doses of  the extract. In conclusion, the 
study suggests that E. americana is potential for further 
development as a blood pressure lowering agent.
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